Patents by Inventor Sergei Andreevich AGEEV

Sergei Andreevich AGEEV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOCYTOKINE FOR ACTIVATING HUMAN IL-10RA RECEPTOR AND USE THEREOF
    Publication number: 20240034764
    Abstract: The present invention relates to the field of biotechnology and medicine, in particular to an immunocytokine for activating the human IL-10R? receptor. The invention further relates to nucleic acids encoding said immunocytokine, expression vectors, host cells and methods for producing same, methods for producing the immunocytokine, pharmaceutical compositions comprising the above immunocytokine, pharmaceutical compositions comprising the above immunocytokine and other therapeutically active compounds, methods for treating an oncological disease and the uses of the immunocytokine or pharmaceutical compositions thereof for treating an oncological disease.
    Type: Application
    Filed: December 10, 2021
    Publication date: February 1, 2024
    Inventors: Aleksey Vladimirovich KONONOV, Iuliia Viktorovna EVDOKIMOVSKAIA, Iana Andreevna SMIRNOVA, Stanislav Rudolfovich EVDOKIMOV, Elena Sergeevna KOLOSOVA, Sergei Andreevich AGEEV, Vladimir Sergeevich TSYMPILOV, Valery Vladimirovich SOLOVYEV, Pavel Andreevich IAKOVLEV, Dmitry Valentinovich MOROZOV
  • IMMUNOCYTOKINE COMPRISING HETERODYMERIC PROTEIN COMPLEX BASED ON IL-15/IL-15RA
    Publication number: 20230011234
    Abstract: The present invention relates to an immunocytokine comprising an heterodimeric protein complex based on IL-15/IL-15R?, and to use thereof as a therapeutic agent, in particular as an agent for the treatment of cancer and an autoimmune disease. The present invention further relates to an immunocytokine comprising a heterodimeric protein complex based on an IL-15/IL-15R? and an immunomodulatory antibody, and to use thereof as a therapeutic agent, in particular as an agent for the treatment of cancer and an autoimmune disease.
    Type: Application
    Filed: September 20, 2020
    Publication date: January 12, 2023
    Inventors: Andrei Borisovich ULITIN, Aleksey Vladimirovich KONONOV, Sergei Andreevich AGEEV, Aleksandr Andreevich GORDEEV, Elena Vladimirovna VINOGRADOVA, Stanislav Rudolfovich EVDOKIMOV, Aleksandra Pavlovna SHMAKOVA, Ivan Vladimirovich MITROSHIN, Dmitry Valentinovich MOROZOV
  • MONOCLONAL ANTIBODY THAT BINDS SPECIFICALLY TO GITR
    Publication number: 20220213209
    Abstract: The present invention relates to biotechnology, in particular to antibodies or antigen-binding fragments thereof, and to use thereof. More particularly, the present invention relates to monoclonal antibodies that specifically bind to GITR. The invention also relates to a nucleic acid encoding said antibody or antigen-binding fragment thereof, an expression vector, a method for preparing said antibody, and use of said antibody in treatment of diseases or disorders associated with GITR.
    Type: Application
    Filed: April 23, 2020
    Publication date: July 7, 2022
    Inventors: Andrei Borisovich ULITIN, Olesya Nikolaevna KOZLOVA, Aleksandr Andreevich GORDEEV, Ksenia Mihailovna BURNYSHEVA, Anastasia Nikolaevna ISHUTINOVA, Aleksandra Aleksandrovna SOZONOVA, Sergei Andreevich AGEEV, Aleksandr Nikolaevich DORONIN, Vladimir Sergeevich TSYMPILOV, Ivan Vladimirovich MITROSHIN, Valery Vladimirovich SOLOVYEV, Iakov Iurevich USTIUGOV, Roman Alekseevich IVANOV, Dmitry Valentinovich MOROZOV
  • Monoclonal antibody to PD-L1
    Patent number: 11236167
    Abstract: The present invention relates to the field of biotechnology and provides antibodies that specifically binds to PD-L1. The invention also relates to DNA encoding said antibodies, to corresponding expression vectors and to methods of producing, and to methods of treatment using said antibodies.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: February 1, 2022
    Inventors: Andrei Borisovich Ulitin, Viktoriia Mikhailovna Ekimova, Ekaterina Vladimirovna Sofronova, Yulia Sergeevna Chernykh, Sergei Andreevich Ageev, Anna Konstantinovna Vladimirova, Aleksei Aleksandrovich Aleksandrov, Pavel Alekseevich Grebnev, Valery Vladimirovich Solovyev, Iakov Iurevich Ustiugov, Pavel Andreevich Iakovlev, Timofey Aleksandrovich Nemankin, Dmitry Valentinovich Morozov
  • MONOCLONAL ANTIBODY TO PD-L1
    Publication number: 20200369771
    Abstract: The present invention relates to the field of biotechnology and provides antibodies that specifically binds to PD-L1. The invention also relates to DNA encoding said antibodies, to corresponding expression vectors and to methods of producing, and to methods of treatment using said antibodies.
    Type: Application
    Filed: April 11, 2018
    Publication date: November 26, 2020
    Inventors: Andrey Borisovich ULITIN, Victoria Mikhailovna EKIMOVA, Ekaterina Vladimirovna SOFRONOVA,, Yulia Sergeevna CHERNYKH, Sergei Andreevich AGEEV, Anna Konstantinovna VLADIMIROVA, Aleksei Aleksandrovich ALEKSANDROV, Pavel Alekseevich GREBNEV, Valery Vladimirovich SOLOVYEV, Iakov Iurevich USTIUGOV, Pavel Andreevich IAKOVLEV, Timofey Aleksandrovich NEMANKIN, Dmitry Valentinovich MOROZOV